Department of Family and Community Medicine, Southern Illinois University School of Medicine, Springfield, Illinois, USA.
Ann Fam Med. 2009 Nov-Dec;7(6):542-6. doi: 10.1370/afm.1017.
We wanted to investigate the frequency of undisclosed changes in the outcomes of randomized controlled trials (RCTs) between trial registration and publication.
Using a retrospective, nonrandom, cross-sectional study design, we investigated RCTs published in consecutive issues of 5 major medical journals during a 6-month period and their associated trials registry entries. Articles were excluded if they did not have an available trial registry entry, did not have analyzable outcomes, or were secondary publications. The primary outcome was the proportion of publications in which the primary outcome of the trial was, without disclosure, changed between that recorded in the trial registry and that reported in the final publication. The secondary outcome was the proportion of publications in which the secondary outcome was changed without disclosure.
We reviewed 158 reports of RCTs and included 110 in the analysis. In 34 (31%), a primary outcome had been changed, and in 77 (70%), a secondary outcome had been changed.
There are substantial and important undisclosed changes made to the outcomes of published RCTs between trial registration and publication. This finding has important implications for the interpretation of trial results. Disclosure and discussion of changes would improve transparency in the performance and reporting of trials.
我们旨在调查随机对照试验(RCT)在注册和发表之间,其结局结果发生未披露变更的频率。
采用回顾性、非随机、横断面研究设计,我们调查了在 6 个月期间连续出版的 5 种主要医学期刊中的 RCT 及其相关的试验注册条目。如果文章没有可用的试验注册条目、没有可分析的结局结果或为二次出版物,则将其排除在外。主要结局是在试验注册中记录的试验主要结局与最终出版物报告的结局之间,未经披露而发生变更的出版物比例。次要结局是未经披露而发生变更的次要结局的比例。
我们回顾了 158 篇 RCT 报告,并对其中的 110 篇进行了分析。在 34 项研究(31%)中,主要结局发生了变更,在 77 项研究(70%)中,次要结局发生了变更。
在 RCT 的注册和发表之间,发表的 RCT 结局发生了大量重要的未披露变更。这一发现对试验结果的解释具有重要意义。对变更的披露和讨论将提高试验执行和报告的透明度。